Deriving actionable strategies to enhance cancer immunotherapy response [ 2018 - ]

Research Grant

Researchers: Dr Miles Andrews (Principal investigator)

Brief description Cancer immunotherapy is an increasingly common treatment used to treat several types of advanced cancers. Whilst it can be dramatically effective in a minority of patients, many patients do not respond to the treatment and our ability to predict who will not benefit is limited. This project aims to study distinct aspects of tumour immunology in patients receiving immunotherapy treatments in order to identify better predictors and more widely-effective immunotherapy treatment strategies.

Funding Amount $438,768.00

Funding Scheme Early Career Fellowships

Notes CJ Martin Biomedical ECF